Icariin Protects Against Glucocorticoid-Induced Osteoporosis In Vitro and Prevents Glucocorticoid-Induced Osteocyte Apoptosis In Vivo

Cell Biochemistry and Biophysics

Volumn 67, Issue 1, 2013, Pages 189-197

  Feng, Rongjie ^a   Feng, Li ^a   Yuan, Zenong ^a   Wang, Dachuan ^a   Wang, Feng ^a   Tan, Bingyi ^a   Han, Shijie ^a   Li, Tao ^a   Li, Dong ^a   Han, Yong ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Glucocorticoid induced osteoporosis; Icariin; Osteocyte apoptosis

Indexed keywords

ANIMALIA; RATTUS;

ALKALINE PHOSPHATASE; COLLAGEN; DEXAMETHASONE; ESTROGEN RECEPTOR ALPHA; FLAVONOID; GLUCOCORTICOID; HERBACEOUS AGENT; ICARIIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL; APOPTOSIS; ARTICLE; BLOOD; BONE DENSITY; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CYTOLOGY; DRUG EFFECT; FEMALE; METABOLISM; OSTEOCYTE; OSTEOPOROSIS; PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ALKALINE PHOSPHATASE; ANIMALS; APOPTOSIS; BONE DENSITY; CELLS, CULTURED; COLLAGEN; DEXAMETHASONE; DRUGS, CHINESE HERBAL; ESTROGEN RECEPTOR ALPHA; FEMALE; FLAVONOIDS; GLUCOCORTICOIDS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OSTEOCYTES; OSTEOPOROSIS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84883453419     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-013-9533-8     Document Type: Article

References (51)

1. Liu, Y., Porta, A., Peng, X., Gengaro, K., Cunningham, E. B., Li, H., et al. (2004). Prevention of glucocorticoid-induced apoptosis in osteocytes and osteoblasts by calbindin-D28k. Journal of Bone and Mineral Research, 19(3), 479-490.
2. Patschan, D., Loddenkemper, K., & Buttgereit, F. (2001). Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone, 29(6), 498-505.
3. Reid, I. R. (1997). Glucocorticoid osteoporosis-mechanisms and management. European Journal of Endocrinology, 137(3), 209-217.
4. Lukert, B. P., & Raisz, L. G. (1990). Glucocorticoid-induced osteoporosis: pathogenesis and management. Annals of Internal Medicine, 112(5), 352-364.
5. Feher, J. J., & Wasserman, R. H. (1979). Intestinal calcium-binding protein and calcium absorption in cortisol-treated chicks: effects of vitamin D3 and 1, 25-dihydroxyvitamin D3. Endocrinology, 104(2), 547-551.
6. Manolagas, S. C. (2000). Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocrine Reviews, 21(2), 115-137.
7. Canalis, E., & Delany, A. M. (2002). Mechanisms of glucocorticoid action in bone. Annals of the New York Academy of Sciences, 966, 73-81.
8. Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998). Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. The Journal of Clinical Investigation, 102(2), 274-282.
9. Bonewald, L. F., & Johnson, M. L. (2008). Osteocytes, mechanosensing and Wnt signaling. Bone, 42(4), 606-615.
10. Manolagas, S. C. (2000). Corticosteroids and fractures: a close encounter of the third cell kind. Journal of Bone and Mineral Research, 15(6), 1001-1005.
11. Kitase, Y., Barragan, L., Qing, H., Kondoh, S., Jiang, J. X., Johnson, M. L., et al. (2010). Mechanical induction of PGE2 in osteocytes blocks glucocorticoid-induced apoptosis through both the beta-catenin and PKA pathways. Journal of Bone and Mineral Research, 25(12), 2657-2668.
12. Adachi, J. D., Bensen, W. G., Bianchi, F., Cividino, A., Pillersdorf, S., Sebaldt, R. J., et al. (1996). Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup. Journal of Rheumatology, 23(6), 995-1000.
13. Ringe, J. D., Coster, A., Meng, T., Schacht, E., & Umbach, R. (1999). Treatment of glucocorticoid-induced osteoporosis with alfacalcidol/calcium versus vitamin D/calcium. Calcified Tissue International, 65(4), 337-340.
14. Eastell, R., Devogelaer, J. P., Peel, N. F., Chines, A. A., Bax, D. E., Sacco-Gibson, N., et al. (2000). Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patients. Osteoporosis International, 11(4), 331-337.
15. Boutsen, Y., Jamart, J., Esselinckx, W., & Devogelaer, J. P. (2001). Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone. Journal of Bone and Mineral Research, 16(1), 104-112.
16. Crandall, C. (2002). Parathyroid hormone for treatment of osteoporosis. Archives of Internal Medicine, 162(20), 2297-2309.
17. Sambrook, P. N. (2007). Anabolic therapy in glucocorticoid-induced osteoporosis. New England Journal of Medicine, 357(20), 2084-2086.
18. Bitto, A., Burnett, B. P., Polito, F., Levy, R. M., Marini, H., Di Stefano, V., et al. (2009). Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate. British Journal of Pharmacology, 156(8), 1287-1295.
19. Xu, D., Yang, W., Zhou, C., Liu, Y., & Xu, B. (2010). Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats. Planta Medica, 76(16), 1809-1813.
20. Mok, S. K., Chen, W. F., Lai, W. P., Leung, P. C., Wang, X. L., Yao, X. S., et al. (2010). Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells. British Journal of Pharmacology, 159(4), 939-949.
21. Zhang, G., Qin, L., & Shi, Y. (2007). Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial. Journal of Bone and Mineral Research, 22(7), 1072-1079.
22. Nian, H., Ma, M. H., Nian, S. S., & Xu, L. L. (2009). Antiosteoporotic activity of icariin in ovariectomized rats. Phytomedicine, 16(4), 320-326.
23. Wang, F. S., Ko, J. Y., Yeh, D. W., Ke, H. C., & Wu, H. L. (2008). Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss. Endocrinology, 149(4), 1793-1801.
24. Gu, G., Hentunen, T. A., Nars, M., Harkonen, P. L., & Vaananen, H. K. (2005). Estrogen protects primary osteocytes against glucocorticoid-induced apoptosis. Apoptosis, 10(3), 583-595.
25. Yun, S. I., Yoon, H. Y., Jeong, S. Y., & Chung, Y. S. (2009). Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3beta. Journal of Bone and Mineral Metabolism, 27(2), 140-148.
26. Hsieh, T. P., Sheu, S. Y., Sun, J. S., & Chen, M. H. (2011). Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-kappaB regulated HIF-1alpha and PGE(2) synthesis. Phytomedicine, 18(2-3), 176-185.
27. Han, E. H., Kim, H. G., Hwang, Y. P., Song, G. Y., & Jeong, H. G. (2010). Prostaglandin E2 induces CYP1B1 expression via ligand-independent activation of the ERalpha pathway in human breast cancer cells. Toxicological Sciences, 114(2), 204-216.
28. Zheng, D., Peng, S., Yang, S. H., Shao, Z. W., Yang, C., Feng, Y., et al. (2012). The beneficial effect of Icariin on bone is diminished in osteoprotegerin-deficient mice. Bone, 51(1), 85-92.
29. Xie, F., Wu, C. F., Lai, W. P., Yang, X. J., Cheung, P. Y., Yao, X. S., et al. (2005). The osteoprotective effect of Herba epimedii (HEP) extract in vivo and in vitro. Evidence-Based Complementary and Alternative Medicine, 2(3), 353-361.
30. Huang, J., Yuan, L., Wang, X., Zhang, T. L., & Wang, K. (2007). Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro. Life Sciences, 81(10), 832-840.
31. Ma, H. P., Ming, L. G., Ge, B. F., Zhai, Y. K., Song, P., Xian, C. J., et al. (2011). Icariin is more potent than genistein in promoting osteoblast differentiation and mineralization in vitro. Journal of Cellular Biochemistry, 112(3), 916-923.
32. Chen, K. M., Ge, B. F., Liu, X. Y., Ma, P. H., Lu, M. B., Bai, M. H., et al. (2007). Icariin inhibits the osteoclast formation induced by RANKL and macrophage-colony stimulating factor in mouse bone marrow culture. Pharmazie, 62(5), 388-391.
33. Rochefort, G. Y., Pallu, S., & Benhamou, C. L. (2010). Osteocyte: the unrecognized side of bone tissue. Osteoporosis International, 21(9), 1457-1469.
34. Robling, A. G., Bellido, T., & Turner, C. H. (2006). Mechanical stimulation in vivo reduces osteocyte expression of sclerostin. The Journal of Musculoskeletal and Neuronal Interactions, 6(4), 354.
35. Vance, J., Galley, S., Liu, D. F., & Donahue, S. W. (2005). Mechanical stimulation of MC3T3 osteoblastic cells in a bone tissue-engineering bioreactor enhances prostaglandin E2 release. Tissue Engineering, 11(11-12), 1832-1839.
36. Basso, N., & Heersche, J. N. (2006). Effects of hind limb unloading and reloading on nitric oxide synthase expression and apoptosis of osteocytes and chondrocytes. Bone, 39(4), 807-814.
37. Meng, L., Cheng, Z., Rong-xin, H., & Li-feng, C. (2012). Icariin associated with exercise therapy is an effective treatment for postmenopausal osteoporosis. Chinese Medical Journal (English Edition), 125(10), 1784-1789.
38. Seeman, E. (2006). Osteocytes-martyrs for integrity of bone strength. Osteoporosis International, 17(10), 1443-1448.
39. Ma, Y. L., Cain, R. L., Halladay, D. L., Yang, X., Zeng, Q., Miles, R. R., et al. (2001). Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology, 142(9), 4047-4054.
40. Noble, B. S., Stevens, H., Loveridge, N., & Reeve, J. (1997). Identification of apoptotic changes in osteocytes in normal and pathological human bone. Bone, 20(3), 273-282.
41. Tatsumi, S., Ishii, K., Amizuka, N., Li, M., Kobayashi, T., Kohno, K., et al. (2007). Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metabolism, 5(6), 464-475.
42. Verborgt, O., Gibson, G. J., & Schaffler, M. B. (2000). Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. Journal of Bone and Mineral Research, 15(1), 60-67.
43. Kogianni, G., Mann, V., & Noble, B. S. (2008). Apoptotic bodies convey activity capable of initiating osteoclastogenesis and localized bone destruction. Journal of Bone and Mineral Research, 23(6), 915-927.
44. Zand, R. S., Jenkins, D. J., & Diamandis, E. P. (2000). Steroid hormone activity of flavonoids and related compounds. Breast Cancer Research and Treatment, 62(1), 35-49.
45. Liu, J., Ye, H., & Lou, Y. (2005). Determination of rat urinary metabolites of icariin in vivo and estrogenic activities of its metabolites on MCF-7 cells. Pharmazie, 60(2), 120-125.
46. Bhargavan, B., Gautam, A. K., Singh, D., Kumar, A., Chaurasia, S., Tyagi, A. M., et al. (2009). Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signaling. Journal of Cellular Biochemistry, 108(2), 388-399.
47. Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T. (1999). Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. The Journal of Clinical Investigation, 104(10), 1363-1374.
48. Kousteni, S., Bellido, T., Plotkin, L. I., O'Brien, C. A., Bodenner, D. L., Han, L., et al. (2001). Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell, 104(5), 719-730.
49. Kousteni, S., Han, L., Chen, J. R., Almeida, M., Plotkin, L. I., Bellido, T., et al. (2003). Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. The Journal of Clinical Investigation, 111(11), 1651-1664.
50. Chung, B. H., Kim, J. D., Kim, C. K., Kim, J. H., Won, M. H., Lee, H. S., et al. (2008). Icariin stimulates angiogenesis by activating the MEK/ERK- and PI3 K/Akt/eNOS-dependent signal pathways in human endothelial cells. Biochemical and Biophysical Research Communications, 376(2), 404-408.
51. Pang, W. Y., Wang, X. L., Mok, S. K., Lai, W. P., Chow, H. K., Leung, P. C., et al. (2010). Naringin improves bone properties in ovariectomized mice and exerts oestrogen-like activities in rat osteoblast-like (UMR-106) cells. British Journal of Pharmacology, 159(8), 1693-1703.